Daily Stock Analysis, RMD, ResMed Inc, priceseries

ResMed Inc. Daily Stock Analysis
Stock Information
Open
250.01
Close
247.28
High
251.79
Low
245.69
Previous Close
254.60
Daily Price Gain
-7.32
YTD High
259.59
YTD High Date
Jan 3, 2022
YTD Low
208.64
YTD Low Date
Jan 28, 2022
YTD Price Change
-11.78
YTD Gain
-4.55%
52 Week High
300.34
52 Week High Date
Sep 9, 2021
52 Week Low
178.15
52 Week Low Date
Mar 8, 2021
52 Week Price Change
69.04
52 Week Gain
38.74%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 31. 2017
67.41
Jun 27. 2017
73.17
19 Trading Days
8.55%
Link
LONG
Nov 26. 2018
101.64
Dec 17. 2018
108.17
14 Trading Days
6.43%
Link
LONG
Apr 25. 2019
99.61
May 29. 2019
109.16
23 Trading Days
9.59%
Link
LONG
Jun 15. 2020
161.68
Jul 13. 2020
185.57
19 Trading Days
14.77%
Link
LONG
Nov 2. 2020
194.73
Nov 18. 2020
209.71
12 Trading Days
7.69%
Link
LONG
Mar 31. 2021
192.70
Apr 29. 2021
206.76
20 Trading Days
7.30%
Link
LONG
Jun 9. 2021
210.94
Jul 14. 2021
244.74
24 Trading Days
16.02%
Link
Company Information
Stock Symbol
RMD
Exchange
NYSE
Company URL
http://www.resmed.com
Company Phone
8587462400
CEO
Mick Farrell
Headquarters
California
Business Address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA 92123
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000943819
About

ResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its product portfolio includes obstructive sleep apnea, and other respiratory disorders that occur during sleep. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Description

ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.